Precision Launches Hemophilia B Test

Precision BioLogic, a Halifax medtech company that sells diagnostic testing supplies, has launched a new product for the bleeding disorder Hemophilia B.
The Hemophilia test, recently approved by Health Canada, is in response to increasing market demand for chromogenic assays and is the only Hemophilia B test of its kind available in the country, Precision said in a statement. Chromogenic assays